Entweder 10000% oder Totalverlust
30 Millionen neue Aktien im Februar
insgesamt sollen 300 Millionen in der Hauptversammlung beschlossen werden.
das steht alles in dem 10Q-Filing ,das schon wieder gestern neu veröffentlicht wurde mitsamt den convertible Bondsowners diesmal
und dazu steht dann auch weiter unten unter :
Management’s Discussion and Analysis of Financial Condition and Results of Operations
As of September 30, 2002 our cash on hand was $19,000. We are actively engaged in seeking additional financing in a variety of venues and formats and we continue to impose actions designed to minimize our operating losses
Our Independent Auditors have Stated that Our Recurring Losses from Operations and Our Accumulated Deficit Raise Substantial Doubt about Our Ability to Continue as a Going Concern.
The report of KPMG LLP dated February 8, 2002 covering the December 31, 2001 consolidated financial statements contains an explanatory paragraph that states that our recurring losses from operations and accumulated deficit raise substantial doubt about our ability to continue as a going concern.
As we issue shares of our common stock to Townsbury and Bristol pursuant to the Recent Financings and the investors then resell the common stock, our common stock price may decrease due to the additional shares in the market. As the price of our common stock decreases, and if we or as we decide to draw down on the equity line of credit, and as we are required to issue shares upon conversions of the debentures and Class B warrants, we will be required to issue more shares of our common stock for any given dollar amount invested by Townsbury and Bristol. This may encourage short sales, which could place further downward pressure on the price of our common stock.
Because the Investors in the Recent Financings are Residents of Foreign Countries, It May be Difficult or Impossible to Obtain or Enforce Judgments Against Them and the Investors are also Subject to United States and Foreign Laws that Could Affect Our Ability to Access the Funds.
Townsbury, Bristol, and the unaffiliated investors who comprise CIG are off-shore investors and a substantial portion of their assets are located outside of the United States. As a result, it may be difficult or impossible to effect service of process on the investors within the United States
We Have Recently Reduced the Exercise Price of Certain Warrants Issued to Investors Which In Turn May Result in Dilution to Existing Shareholders As Well As a Downward Pressure on the Trading Price of Our Common Stock....
naja man kann das Ganze natürlich auch als Glücksspiel sehen,nur sollte man sich dann den Chart sehr genau ansehen und schnell handeln,momentan sind sie offenbar bemüht die negativen News zu überspielen durch Public Relation,jede Woche was Neues,die Methode ist bekannt.
P.S ein teil meiner Kontronbestände mußte dafür herhalten.
--------------------------------------------------
Calypte Biomedical to Announce Fourth Quarter and Year-End 2002 Financial Results On February 27th
ALAMEDA, Calif., Feb 6, 2003 (BUSINESS WIRE) -- Calypte Biomedical Corporation (OTCBB:CALY) announced it will host a conference call on Thursday, February 27, at 8:00 am (PDT), 11:00 am (EDT) to discuss its fourth quarter and year-end 2002 financial results.
Investors in the U.S. and Canada interested in participating in the conference call may dial 877/282-0743 and reference the Calypte Biomedical call. International investors may dial 703/871-3073. Calypte recommends dialing into the call approximately 10 minutes prior to the scheduled start time.
A live webcast of the conference call will be available on the investors section of the company's website at www.calypte.com. The webcast will be available until March 27, 2003.
A replay will be available through March 1, 2003 by calling 888/266-2081. International callers should dial 703/925-2533 for the replay. The replay confirmation code is 6411592.
About Calypte Biomedical:
Calypte Biomedical Corporation is dedicated to the development and commercialization of urine-based diagnostic products and services for the Human Immunodeficiency Virus Type 1 (HIV-1), sexually transmitted diseases and other infectious diseases. Calypte's tests include the screening EIA and supplemental Western Blot tests, the only two FDA-approved HIV-1 antibody tests that can be used on urine samples. When compared with existing blood-based tests, the Company's testing algorithms are non-invasive, easier to use, less expensive and have significantly less risk than blood-based testing, and they have 99.7% sensitivity in subjects previously identified as HIV-1 infected and 100% specificity in subjects at low risk when combined with the urine-based Western Blot supplemental test. The company believes that accurate, non-invasive urine-based testing methods for HIV and other infectious diseases may make important contributions to public health by helping to foster an environment in which testing may be done safely, economically and painlessly. Calypte markets its products in countries worldwide through international distributors and strategic partners.
CONTACT: Calypte Biomedical Corporation
Richard Brounstein, 510/749-5156
rbrounstein@calypte.com
or
Lippert/Heilshorn & Associates
Brendan Lahiff, 415/433-3777 (Investor Relations)
brendan@lhai-sf.com
Kirsten Chapman, 415/433-3777 (Investor Relations)
URL: http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2003 Business Wire. All rights reserved.
aber da gibts noch nen interessanten Wert für Euch Spieler:MEMI hat gestern über 40% zugelegt,da war Cataldo CEO bis vor Kurzem
MEMI kriegste nur über market maker:vermutlich Equity Transfer Services Inc., Toronto, ON M5H 4C3,laut Yahoo wohl auch über andere broker,ist ein OTC-wert,eigentlich pleite,hat aber noch ne homepage.Beeindruckend die historischen Kurse bei http://table.finance.yahoo.com/k?s=memi.pk&g=d
ist kein ernstgemeinter Vorschlag!
gruß grenke
Steht schon ein Ausgabepreis für die Aktien fest? Ich hab auch schon mal einen gelesen, der lag aber nur bei 0,01$, d.h. es kämen gerade mal 6 Mio. $ zusammen und außerdem sind die Aktien laut meinen Quellen nur für Investoren gedacht!
@grenke: Weißt du da was genaueres?
Gruß masteruz
Euer masteruz
http://finance.lycos.com/
Einfach anmelden und dann realtimen und zwar kostenlos!!!
Gruß masteruz
Vonwegen, der Kurs wird ausschließlich von den Ami´s bestimmt. Die schielen doch mit einem Auge auch zu uns und schaun auf den Kursverlauf hier. Es fehlt jetzt hier nur noch der berühmte Tropfen, der das Faß zum überlaufen bringt und dann ...
gruß hannes